Omega Healthcare Investors (OHI) Non Operating Interest Expenses (2009 - 2026)

Omega Healthcare Investors has disclosed Non Operating Interest Expenses across 16 years of filings, most recently posting $48.1 million for Q2 2026.

• In Q2 2026, Non Operating Interest Expenses fell 9.04% year-over-year to $48.1 million; the TTM figure through Jun 2026 stood at $207.7 million (down 3.43% YoY), while the FY2025 annual figure was $215.0 million, down 3.01% from the prior year.
• Non Operating Interest Expenses came in at $48.1 million for Q2 2026 at Omega Healthcare Investors, down from $49.8 million in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $59.4 million in Q4 2023 to a low of $48.1 million in Q2 2026.
• Average Non Operating Interest Expenses over 5 years is $55.7 million, with a median of $58.0 million recorded in 2024.
• The largest YoY upside for Non Operating Interest Expenses was 6.26% in 2025 against a maximum downside of 9.58% in 2025.
• Over 5 years, Non Operating Interest Expenses stood at $58.5 million in 2022, then increased by 1.61% to $59.4 million in 2023, then decreased by 7.05% to $55.2 million in 2024, then fell by 6.33% to $51.7 million in 2025, then decreased by 7.01% to $48.1 million in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $48.1 million in Q2 2026, $49.8 million in Q1 2026, and $51.7 million in Q4 2025.